Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | WHR1 | P49842 | 1/20 | 0.39 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | NR1I3 | Q14994 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | VDR | P11473 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22097273 | 0.98 | MEN1 (0.47) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL21187001 | 0.92 | MEN1 (0.48) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL22096983 | 0.92 | MEN1 (0.48) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL21187002 | 0.91 | MEN1 (0.47) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL21186852 | 0.89 | MEN1 (0.45) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL22097141 | 0.88 | MEN1 (0.35) | MEN1KMT2AATMWHR1HPGD | |
| SCHEMBL22097184 | 0.88 | MEN1 (0.51) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL21186855 | 0.87 | MEN1 (0.49) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL22097005 | 0.87 | CYP1A1 (0.35) | MEN1KMT2AATMWHR1HPGD | |
| SCHEMBL21186853 | 0.86 | MEN1 (0.45) | MEN1KMT2AATMWHR1NUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11236075-B2 | Organic compound and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-02-01 | — | — | US | disclosed |
| US-20200190065-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11236075-B2 | Organic compound and organic electroluminescence device using the same | ICMT, OR10J3, PIEZO1 | MEN1 1207/4885KMT2A 2500/4885ATM 3884/4885 |
| US-20200190065-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | ICMT, OR10J3, PIEZO1 | MEN1 1207/4885KMT2A 2500/4885ATM 3884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.